exeporfinium chloride (XF-73) / Cystic Fibrosis Foundation, Destiny Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
exeporfinium chloride (XF-73) / Destiny Pharma
NCT03915470: Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection

Completed
2
124
US, RoW
XF-73, Exeporfinium chloride, Placebo, Matched Placebo
Destiny Pharma Plc
Staphylococcal Infections, Surgical Site Infection
01/21
03/21

Download Options